7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Mandibular Diseases D008336 5 associated lipids
Bone Resorption D001862 7 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Bone Neoplasms D001859 5 associated lipids
Fractures, Bone D050723 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Carcinoma D002277 18 associated lipids
Osteonecrosis D010020 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Honma M et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. 2013 J. Bone Miner. Res. pmid:23529793
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Shang M et al. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. 2013 Clin. Biochem. pmid:23531404
Jin J et al. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. 2013 J. Surg. Res. pmid:22487394
Zhan X et al. Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. 2013 Dent Traumatol pmid:22487464
Kim J et al. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. 2013 Clin. Biochem. pmid:23726804
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Ma XN et al. [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:23987492
Naumnik B et al. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. 2013 Adv Med Sci pmid:23959668
Belibasakis GN et al. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. 2013 Int Endod J pmid:22900632
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
Callegari A et al. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23990207
Oshita K et al. [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. 2013 J. UOEH pmid:23475022
Kress DC Invited commentary. 2013 Ann. Thorac. Surg. pmid:23992687
Mozzanega B et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. 2013 J. Bone Miner. Metab. pmid:23479185
de Matos FR et al. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. 2013 J. Oral Maxillofac. Surg. pmid:23992784
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Anastasilakis AD et al. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. 2013 J. Clin. Endocrinol. Metab. pmid:23788684
Wang XF et al. The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. 2013 Mol Med Rep pmid:23440406
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Fu YX et al. Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. 2013 Poult. Sci. pmid:23687158
Lou Z et al. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. 2013 Med. Oncol. pmid:23690270
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Kato R et al. Gap-junction-mediated communication in human periodontal ligament cells. 2013 J. Dent. Res. pmid:23677649
Brown TT et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. 2013 J. Acquir. Immune Defic. Syndr. pmid:23591634
Feng X et al. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. 2013 Clin. Dev. Immunol. pmid:24348674
Levidou G et al. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. 2013 Pathology pmid:23277172
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Shao B et al. [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. 2013 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24321069
Jiang H et al. A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. 2013 BMC Pregnancy Childbirth pmid:24321402
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Zhang J et al. Occlusal effects on longitudinal bone alterations of the temporomandibular joint. 2013 J. Dent. Res. pmid:23340211
Yang B et al. Effect of radiation on the Notch signaling pathway in osteoblasts. 2013 Int. J. Mol. Med. pmid:23340672
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Osorio A et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. 2013 Mol. Cell. Biochem. pmid:23124853
Kim HS et al. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. 2013 Int. J. Mol. Med. pmid:23128413
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Ciccone MM et al. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. 2013 J Cardiovasc Med (Hagerstown) pmid:22772598
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389

Table of Content